Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Hold
686
0.07% 48
2026
Q1
$241K Hold
686
0.07% 48
2025
Q4
$225K Buy
+686
New +$218K 0.07% 52
2025
Q2
Sell
-686
Closed -$214K 50
2025
Q1
$214K Buy
+686
New +$203K 0.07% 47
2024
Q4
Sell
-686
Closed -$221K 51
2024
Q3
$221K Hold
686
0.08% 48
2024
Q2
$214K Buy
+686
New +$202K 0.08% 46

Other funds holding AMGN

HT Partners's AMGN Position: Q2 2026 in Review

HT Partners held its Amgen (AMGN) position steady in Q2 2026 at 686 shares worth $248K. The position accounts for 0.07% of the portfolio, ranked #48.

HT Partners first reported a position in AMGN in Q2 2024 and has held it in 6 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • HT Partners held 686 shares of Amgen worth $248K as of Q2 2026.
  • HT Partners left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.07% of HT Partners's portfolio in Q2 2026, its #48 holding.
  • HT Partners first reported a position in Amgen in Q2 2024 and has held it in 6 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on HT Partners's 13F filing for Q2 2026, filed 16 Jul 2026.